Skip to main content
. Author manuscript; available in PMC: 2011 Sep 24.
Published in final edited form as: Vaccine. 2010 Aug 4;28(41):6740–6748. doi: 10.1016/j.vaccine.2010.07.075

Figure 6.

Figure 6

Protection mediated for antibodies against LFD1 or the full length protein (LF). A/J mice (8 per group) were immunized i.m. with 10 µg of protein adsorbed to alum on days 0, 14 and 28. Animals were subjected to lethal i.p challenge (~105 CFU) with B. anthracis STI spores on day 81. (A) Serum LF-specific IgG responses measured on day 73, (B) TNA titers elicited by LFD1 and LF, and (C) Survival curves after challenge. * denotes higher responses to LF compared with LFD1 (p<0.005).